Disorders Treated With Exposure Therapy: A Clinical Map
By Equipo VRET
Specific phobia, panic with agoraphobia, social anxiety, OCD, PTSD and health anxiety: that is the map of disorders treated with exposure therapy. The list is short because indication does not follow the diagnostic label but the presence of a feared prediction the trial can disprove. These pages walk the indication spectrum picture by picture and mark what changes in each: the stimulus presented, the response withheld, and what the clinician records.
Which disorders are treated with exposure therapy?
The short answer fits in a sentence: those in which the person anticipates a specific harm and organises their behaviour so as never to find out whether it arrives. That pattern, a feared prediction held in place by avoidance, is the actual target of the technique rather than the label typed into the report. And it shows up cleanly in six groups of disorders treated with exposure therapy: specific phobia, panic disorder with agoraphobia, social anxiety disorder, obsessive-compulsive disorder, post-traumatic stress disorder and health anxiety.
Framing it that way has an immediate practical consequence. Two patients carrying the same diagnosis may not share an indication. One avoids the underground because he expects to faint; another avoids it because she expects other passengers to notice her hands shaking. The stimulus that has to be presented differs, the record differs, and so does the criterion for moving up a step. The list of conditions treated with exposure therapy orients the conversation; the case formulation is what decides.
Dog phobia illustrates the point well. On paper it is a specific phobia of the animal subtype, and yet the work turns on a handful of very concrete variables: the size of the animal, whether it is on a lead, barking, distance, and movement towards the patient. A set of graded dog exposure scenarios exists precisely because those variables have to be adjustable one at a time.
What follows works through the disorders treated with exposure therapy one picture at a time, and what matters in each is the difference: what gets presented, what gets withheld, and what ends up written down. Whether a particular patient is suitable, and the situations in which the procedure is inadvisable, sit on a different decision plane with criteria of their own and are not covered here.
Specific phobia: the tightest perimeter
DSM-5-TR describes specific phobia with elements a clinician can check one by one: marked fear or anxiety about a particular object or situation, a response that is almost instantaneous in its presence, active avoidance, fear out of proportion to the actual danger, and persistence for six months or more with associated distress or impairment. The specifiers divide the picture into animal, natural environment, blood-injection-injury and situational types.
That closed perimeter explains why specific phobia is the condition treated with exposure therapy with the longest clinical track record. The stimulus is identified without argument, the progression is built on measurable physical dimensions, and the outcome is checked in behaviour: the patient steps into the lift or does not. Öst documented in addition that in this picture the work can be concentrated into a single prolonged encounter with therapist modelling, without the progression having to be spread across weeks.
The blood-injection-injury subtype is the exception that organises the rule. The dominant response is not sympathetic arousal but a faint of vasovagal mechanism, so presenting the stimulus and waiting is not enough: the classic protocol adds applied muscle tension to hold blood pressure up [CITATION TO VERIFY]. It is the cleanest example of one shared label housing quite different adaptations.
That all of this transfers to a computer-generated environment was established early: the controlled trial by García-Palacios and colleagues (2002) showed that patients with spider phobia accepted virtual exposure and improved on approach behaviour. Neighbouring pictures should not be conflated, though; the line between acrophobia and vertigo is settled by examination rather than by the patient's account of the complaint.
Panic and agoraphobia: two targets that overlap
In panic disorder the feared stimulus is not out in the street, it is inside. The prediction concerns bodily sensation: dizziness announces a faint, tachycardia announces a heart attack, unreality announces loss of control. The agoraphobic layer adds a second stratum, the places where escape would be difficult, and that stratum is situational, which is what gives exposure ground to work on.
Panic is one of those disorders treated with exposure therapy where the technique splits the job with cognitive intervention, and the two fronts are worth keeping apart. One is learning about the patient's own body, deliberately provoked, which is what interoceptive exposure covers and which has a technique of its own. The other is the return to abandoned contexts: public transport, queues, open spaces, increasing distance from home. The agoraphobia exposure scenario handles the second and lets it be walked in an order the real city never grants.
The NICE guideline for panic disorder puts exposure where it belongs: as a component of cognitive behavioural treatment rather than a free-standing intervention. That reading carries weight in practice, because here the reinterpretation of the sensation and the removal of safety behaviours, the anxiolytic in the pocket, the trusted companion, the seat next to the door, count for as much as the approach trial itself.
What the clinician writes down before each trial is the patient's explicit prediction: what they believe will happen, how likely they hold it to be, and what they would do if it did. Afterwards it is set against what actually occurred. That contrast, not the number of minutes endured on the bus, is the clinical material of the session.
Social anxiety: when the stimulus is somebody else's attention
Social anxiety disorder is treated with exposure therapy on considerably less manageable ground: the behaviour of other people. Bringing the patient into a room is not enough; an audience has to be produced that looks, gets distracted, interrupts or asks a question. Hence the weight of the controlled trial by Anderson and colleagues (2013), which compared exposure in virtual reality against group cognitive behavioural exposure treatment in adults with this diagnosis and found comparable improvement at the end of treatment and at twelve-month follow-up.
The clinical subtlety lies in the safety behaviours, which in this picture are fine-grained and easy to miss: rehearsing the sentence before saying it, looking at the floor, speaking fast to get it over with, holding the glass with both hands. If the trial runs with those manoeuvres in play, the patient credits the good outcome to the manoeuvre and the prediction survives intact. Withdrawing them one at a time, and naming the withdrawal out loud, is part of the trial.
The other subtlety is the aim of the trial. In specific phobia the patient checks that the dog does not bite; here, more often, the patient checks that a small rejection happens and lays waste to nothing. The clinician then sets up trials in which the feared outcome is produced in calibrated form: the question with no answer to hand, the awkward silence, the stumble in front of a group. The material on virtual reality exposure for social anxiety sets out how an audience is graded step by step.
None of this is improvised in front of the patient. The sequence of trials, the behaviours withdrawn in each of them and the record that goes with them are written before the session, and reviewed once it ends.
Protocol template by diagnostic picture
The dog phobia protocol in virtual reality, with the full progression, the variables adjusted at each step and the record sheets. It works as a model for adapting the sequence to other indications.
Download the protocolOCD, PTSD and health anxiety: indication with a frame
OCD is treated with exposure therapy only in combination: here the technique never travels alone. The review of variants gathered by Abramowitz made clear that the decisive component is blocking the response that neutralises the obsession: the check, the wash, the mental ritual, the question put to a relative. Presenting the stimulus and allowing the ritual amounts to having presented nothing. The technique that joins the two pieces, exposure and response prevention, has an entry of its own and is not settled in a paragraph; what matters here is that the indication exists and that the frame obliges the clinician to state which response is being withheld.
In PTSD the stimulus is a memory, and that changes the nature of the work: it proceeds on the account of the event and on the reminders the patient has been steadily removing from their life. DSM-5-TR sorts the picture into intrusion, avoidance, negative alterations in cognition and mood, and marked arousal; avoidance is the door through which the technique enters. The ISTSS recommendations place trauma-focused interventions with an exposure component among the first-line options, always with specific training behind them. PTSD is treated with exposure therapy in formats built around that memory, and the prolonged one carries a protocol and a literature of its own.
Health anxiety is the last of the conditions treated with exposure therapy on this map, and it brings a peculiar stimulus: information. Searching symptoms at night, palpating the lump one more time, requesting the redundant blood test, consulting the relative who happens to be a doctor. The trial consists of tolerating bodily uncertainty without checking, which makes the withdrawal of the checks the axis of the plan rather than an addition to it. It is worked through in detail in the material on health anxiety in virtual reality.
The three pictures share a demand. They call for a written formulation, informed consent covering what is going to be done, a plan for what happens if the patient decompensates, and accessible supervision when the case turns difficult. The technique rests on that framework, not on whichever scenario looks most striking.
Comorbidity, differential diagnosis and the order of treatment
The mechanism explains why this behaves as a spectrum of indication rather than a table of equivalences. Craske and colleagues recast extinction in terms of inhibitory learning: the trial does not erase the original fear association, it builds another one that competes with it, and what is therapeutic is that the second is retrieved when the situation comes round again. The 2022 update shifts the emphasis exactly there, onto retrieval at the moment it is needed.
From that model follows the requirement for indication: a testable prediction, not a diagnosis. If the patient cannot state what they fear will happen, or if what they fear admits of no test inside the trial, the technique has no material to work with. Habituation, the dominant explanatory model for decades, remains a phenomenon plainly visible in the session; what it does not support is prognosis, because arousal falling inside a single trial predicts poorly what will be the case months later.
Across the disorders treated with exposure therapy comorbidity is the norm, and it forces a decision about order. With two anxiety pictures the usual move is to start with the one holding up the most avoidance, because dismantling it frees ground for the other. With low mood alongside, the sequence depends on whether inactivity prevents the trials. And in generalised anxiety disorder exposure enters through the door of worry, the sustained trial of the worst imagined consequence and the withdrawal of reassurance-seeking, although the centre of the protocol is occupied by intolerance of uncertainty [CITATION TO VERIFY].
Differential diagnosis settles more than the label does. A fear of driving that begins with a crash may be a situational phobia or PTSD, and the aim of the trial changes completely in each case. The frequent error early in a career is the reverse order: choosing the scenario before formulating the case, then bending the formulation to whatever the scenario happens to allow.
Disorders treated with exposure therapy: from map to plan
Seen as a whole, the catalogue of disorders treated with exposure therapy has one virtue for professional practice: competence transfers. A clinician who can build an exposure hierarchy, record the prediction beforehand and decide when a trial gets repeated applies the same reasoning to fear of flying, to social anxiety and to health anxiety. The stimulus presented changes; the clinical reasoning holding it up does not.
It is also worth being honest about the limits of the list. There are pictures where exposure appears as a minor component and others where it does not appear at all; and there are patients with a clear indication on paper who need preparatory regulation work before the first trial. None of those decisions is taken from a catalogue: they are taken case by case, with the patient in the room and the formulation written down.
For a clinician who wants to see how this spectrum translates into a set of graded scenarios, and what ends up recorded in each session, the practical route is to book a demonstration of the system and walk a case from end to end, from the formulation through to the report.
This article is for informational purposes for psychology professionals. It is not clinical advice for any individual case and does not replace the judgment of the licensed psychologist in charge. VRET is professional clinical-support software, not a CE-marked medical device.
Frequently asked questions
Which disorders treated with exposure therapy have the largest trial base?
The bulk of the research sits in specific phobia and social anxiety disorder, followed by panic disorder with agoraphobia. These are the pictures where the stimulus is identified clearly, the progression is built on observable dimensions and the outcome is checked in behaviour, which makes them easier to study under controlled conditions. In PTSD and in OCD the evidence also supports the technique, but it arrives with more conditions attached: specific training, an explicit frame and a plan for decompensation. Health anxiety is the most recent of the six conditions treated with exposure therapy. For a clinician the useful reading is not a hierarchy of evidence but the fact that the volume of studies tracks how easy it is to delimit the stimulus in each picture.
Is exposure used in generalised anxiety disorder?
It enters as a component rather than as the axis of the protocol. The difficulty is that the feared stimulus is not an external situation that can be presented, but a chain of worry about future and improbable events. The usual adaptation is to work with the worst imagined consequence in sustained form, and above all to withdraw what keeps the worry running: continuous reassurance-seeking, news checking, defensive planning for scenarios that will not occur. Even so, treatment in this picture is generally organised around intolerance of uncertainty, and exposure is subordinated to that formulation. It is the clearest example of an indication that cannot be read off the diagnostic label.
What changes in the indication when there is comorbidity?
The order changes, and the order is a clinical decision worth putting in writing. With two anxiety pictures, the most widespread practice is to begin with the one holding up the most avoidance in the patient's life, because every piece of avoidance dismantled frees ground for the next. With depressive symptoms alongside, the question is whether inactivity and hopelessness allow between-session trials to be sustained; if they do not, behavioural activation comes first. Where there is alcohol use or an as-needed anxiolytic, it has to be weighed as a possible safety behaviour, because a trial run under its effect teaches very little. Comorbidity rarely removes the indication: it reorders it in time.
What does the clinician record to justify the indication?
Four pieces, and none of them is the name of a scenario. First, the formulation: what the patient predicts will happen, what they do to avoid finding out, and what that manoeuvre buys them. Second, the target behaviour in observable terms, of the order of taking the lift daily or holding a conversation with a stranger. Third, the planned sequence of trials with the variables adjusted in each one and the safety behaviours withdrawn along the way. Fourth, informed consent covering what the procedure involves, including the option of stopping it at any point. With those four pieces the clinical record supports the decision under external review; without them the file documents activity rather than judgment.
What does a practice need to cover these indications with virtual reality?
In material terms, a headset and a clear space of about two metres by two; in clinical terms, prior competence in exposure work, which is what really limits the scope. On the catalogue side, useful coverage means graded scenarios for the conditions treated with exposure therapy that turn up most often: the frequent specific phobias, social anxiety and the situational component of panic with agoraphobia. VRET plans currently run at $119 a month for Starter, $289 for Clinic and $1,499 for Enterprise, with a 30-day money-back window, and the sensible way to assess fit is a demonstration walking through a complete case before deciding. What no tool supplies is the formulation: that is signed by the licensed clinician in charge.
Keep reading
Can Online Exposure Therapy Work? The Clinical Limits
Whether online exposure therapy can be done at all, what professional support actually contributes, and which credentials authorise a clinician to deliver it.
Practice managementContraindications to Exposure Therapy: Risks and Cautions
Contraindications to exposure therapy, whether it can make anxiety worse and who it does not suit: exclusion criteria and clinical cautions.
Practice managementSUDS Scale: How to Measure Anxiety During Exposure
What the SUDS scale is, how anxiety is measured during exposure, and which indicators actually show whether a course of treatment is moving.
VRET is professional clinical-support software, not a CE-marked medical device. Clinical supervision remains with the licensed psychologist in charge.